1. Home
  2. CTMX vs MOFG Comparison

CTMX vs MOFG Comparison

Compare CTMX & MOFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • MOFG
  • Stock Information
  • Founded
  • CTMX 2008
  • MOFG 1934
  • Country
  • CTMX United States
  • MOFG United States
  • Employees
  • CTMX N/A
  • MOFG N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • MOFG Major Banks
  • Sector
  • CTMX Health Care
  • MOFG Finance
  • Exchange
  • CTMX Nasdaq
  • MOFG Nasdaq
  • Market Cap
  • CTMX 544.2M
  • MOFG 628.8M
  • IPO Year
  • CTMX 2015
  • MOFG N/A
  • Fundamental
  • Price
  • CTMX $3.32
  • MOFG $29.22
  • Analyst Decision
  • CTMX Strong Buy
  • MOFG Buy
  • Analyst Count
  • CTMX 5
  • MOFG 2
  • Target Price
  • CTMX $5.30
  • MOFG $34.50
  • AVG Volume (30 Days)
  • CTMX 4.3M
  • MOFG 119.7K
  • Earning Date
  • CTMX 11-06-2025
  • MOFG 10-23-2025
  • Dividend Yield
  • CTMX N/A
  • MOFG 3.32%
  • EPS Growth
  • CTMX 263.20
  • MOFG N/A
  • EPS
  • CTMX 0.49
  • MOFG N/A
  • Revenue
  • CTMX $141,100,000.00
  • MOFG $68,312,000.00
  • Revenue This Year
  • CTMX N/A
  • MOFG $241.13
  • Revenue Next Year
  • CTMX N/A
  • MOFG $6.67
  • P/E Ratio
  • CTMX $6.80
  • MOFG N/A
  • Revenue Growth
  • CTMX 18.01
  • MOFG N/A
  • 52 Week Low
  • CTMX $0.40
  • MOFG $24.62
  • 52 Week High
  • CTMX $3.49
  • MOFG $34.56
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 75.86
  • MOFG 52.86
  • Support Level
  • CTMX $3.11
  • MOFG $27.83
  • Resistance Level
  • CTMX $3.39
  • MOFG $28.71
  • Average True Range (ATR)
  • CTMX 0.24
  • MOFG 0.60
  • MACD
  • CTMX 0.10
  • MOFG 0.00
  • Stochastic Oscillator
  • CTMX 90.91
  • MOFG 64.75

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About MOFG MidWestOne Financial Gp

MidWestOne Financial Group Inc is a bank holding company engaged in delivering relationship-based business and personal banking products and services. The Bank provides commercial loans, real estate loans, agricultural loans, credit card loans, and consumer loans. It also provides deposit products including demand and interest checking accounts, savings accounts, money market accounts, and time deposits. The Bank also provides products and services including treasury management, Zelle, online and mobile banking, debit cards, ATMs, and safe deposit boxes. The Bank offers its products and services through its network of full-service banking offices. the Bank's investments services department offers financial planning, investment advisory, and retail securities brokerage services.

Share on Social Networks: